MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) has announced the completion and delivery of its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, advancing the commercialization of its voice-based impairment detection technology for workplace safety. The kiosks utilize artificial intelligence to analyze short voice samples for over 140 acoustic markers associated with potential alcohol, drug, or fatigue-related impairment, with models trained on more than 50 million data points.
The prototypes are now entering testing, validation, and data-analysis phases involving industry participants, speech specialists, and software engineers as the company works to refine its predictive models and assess real-world performance. MindBio is targeting safety-sensitive industries including mining, aviation, construction, transportation, and law enforcement, where large workforces and operational risks can make conventional breath, saliva, urine, and laboratory testing costly and time-consuming. The company’s approach is designed to provide rapid, scalable, and less invasive initial screening, with individuals flagged for potential impairment able to undergo additional evaluation using established testing protocols.
This development is significant as it represents a step toward more efficient and less intrusive impairment detection in high-risk workplaces. Traditional methods such as breathalyzers and urine tests can be logistically challenging and may be resisted by employees due to privacy concerns. Voice-based analysis offers a quicker alternative that could be deployed at entry points or check-in stations, potentially reducing accidents and improving safety compliance.
MindBio’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
For more information, visit the company’s website at www.MindBioTherapeutics.com. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
